In the context of ME/CFS and Long COVID, where glucose metabolism is often dysregulated and insulin resistance can develop, the ability to efficiently burn fats for energy becomes paramount
The second is Foundayos ramp into the oral obesity market, where early prescriptions skewed heavily toward patients new to the category, suggesting it expands the market rather than cannibalizing the injectables
Pickart, L., Vasquez-Soltero, J
Slower than some competitors, though repeat orders ship faster
Without controlled studies, we cannot know whether observed improvements result from the treatment itself, placebo effects, natural weight fluctuation, or simple photograph manipulation
Their head-to-head efficacy gains threaten incumbent premium pricing, particularly in emerging markets